The results of our in vitro and in xenograft animal model experiments demonstrate that prostate cancer cells with high TOPK expression have increased migratory and invasive capacity (Figures 2 and 4), and knocking down TOPK decreased the metastatic potential of these cells. Here, PBK is linked to prostate carcinoma.